CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,348 enrolled
Drug / intervention
Laddrbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03392883
NCT03392883N/ACompleted

Scaling Up Science-based Mental Health Interventions in Latin America

Dartmouth-Hitchcock Medical Center·interventional·Posted Jan 8, 2018·Updated Nov 9, 2022

In Brief

A clinical study evaluating Laddr for Depression and Problematic Alcohol Use. Completed, enrolled 1,348 participants across 6 sites.

Detailed Summary

Conduct systematic, multi-site mental health implementation research in both rural and urban primary care settings with a broad group of stakeholders in the US and Latin America.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesColombia

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 8, 2018
Enrollment StartFeb 13, 2018
Primary CompletionMar 18, 2021
Study CompletionAug 31, 2021
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 8.5 years ago

Interventions

Laddrbehavioral

Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. Specifically, the core functionality of Laddr (e.g., problem-solving therapy) will be structured to focus on an end user's management of depression and its impact on their functioning and quality of life. The program will secondarily focus on problematic alcohol use and its relationship to depression management.